Efficacy and safety of the combined oral contraceptive ethinylestradioldrospirenone (Yasmin®) in healthy chinese women: A randomized, open-label, controlled, multicentre trial

Clinical Drug Investigation

Volumn 30, Issue 6, 2010, Pages 387-396

  Guang Sheng, Fan ^a   Mei Lu, Bian ^b   Li Nan, Cheng ^c,d   Xiao Ming, Cao ^e   Zi Rong, Huang ^f   Zi Yan, Han ^g   Xiao Ping, Jing ^h   Jian, Li ⁱ   Shu Ying, Wu ^j   Cheng Liang, Xiong ^k   Zheng Ai, Xiong ^l   Tian Fu, Yue ^m  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c School of Medicine   (China)

^d SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

^e Tianjin Women and Children's Health Center   (China)

^f FUDAN UNIVERSITY   (China)

^g SICHUAN UNIVERSITY   (China)

^h CAPITAL MEDICAL UNIVERSITY   (China)

ⁱ CAPITAL MEDICAL UNIVERSITY   (China)

^j PEKING UNIVERSITY THIRD HOSPITAL   (China)

^k HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^l CHONGQING MEDICAL UNIVERSITY   (China)

^m TIANJIN MEDICAL UNIVERSITY   (China)

more..

Author keywords

Ethinylestradioldesogestrel; Ethinylestradioldrospirenone; Hormonal contraceptives; Oral contraceptives; Therapeutic use

Indexed keywords

DESOGESTREL; DROSPIRENONE PLUS ETHINYLESTRADIOL;

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST TENDERNESS; CHILL; CHINESE; CHOLECYSTITIS; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEART PALPITATION; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; INSOMNIA; LIBIDO DISORDER; MASTALGIA; MEDICAL PARAMETERS; MENSTRUAL DISTRESS QUESTIONNAIRE; NAUSEA AND VOMITING; NORMAL HUMAN; PEARL INDEX; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; VAGINA BLEEDING; WEIGHT GAIN;

ADULT; ANDROSTENES; BODY WATER; BODY WEIGHT; CHINA; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENSTRUAL CYCLE;

EID: 77952051604     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11318460-000000000-00000     Document Type: Article

References (17)

1. Parsey KS, Pong A. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 2000 Feb; 61 2:105-11
2. Muhn P, Fuhrmann U, Fritzemeier KH, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann N Y Acad Sci 1995 Jun. 12;761:311-35
3. Runnenbaum B, Rabe T. Gynäkologische Endokrinologie. Berlin: Springer Verlag 1994;413
4. Oelkers WH. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric 2005 Oct; 8 Suppl. 3:19-27
5. Burke AE, Blumenthal PD. Successful use of oral contraceptives. Semin Reprod Med 2001 Dec; 19 4:313-21
6. Borges LE, Andrade RP, Aldrighi JM, et al. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception 2006 Dec; 74 6:446-50
7. Brown C, Ling F, Wan J. A new monophasic oral contraceptive containing drospirenone: effect on premenstrual symptoms. J Reprod Med 2002 Jan; 47 1:14-22
8. Dell DL. Premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of another disorder. Clin Obstet Gynecol 2004 Sep; 47 3:568-75
9. Oelkers WK. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 1996 Apr; 61 4:166-71
10. Eriksson E, Sundblad C, Lisjo P, et al. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992 May-Jul; 17 (2-3): 195-204
11. Oelkers W. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone. Eur J Contracept Reprod Health Care 2002 Dec; 7 Suppl. 3:19-26
12. discussion 42-3
13. O'Brien PM. The premenstrual syndrome: areview. J Reprod Med 1985 Feb; 30 2:113-26
14. Sitruk-Ware R. Pharmacology of different progestogens: the special case of drospirenone. Climacteric 2005 Oct; 8 Suppl. 3:4-12
15. Teichmann A. Pharmacology of estradiol valerate/dienogest. Climacteric 2003 Aug; 6 Suppl. 2:17-23
16. Elger W, Beier S, Pollow K, et al. Conception and pharmacodynamic profile of drospirenone. Steroids 2003 Nov; 68 (10-13): 891-905
17. Oelkers W. Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol Cell Endocrinol 2004 Mar. 31;217 (1-2): 255-61